By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced that Cambridge Bioscience will exclusively distribute its desktop nanofabrication equipment in the UK and Ireland.

The deal includes NanoInk's NLP 2000 System and DPN 5000 System.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.